Barrow, Hanley, Mewhinney & Strauss’s Innovex International INVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51
Closed -$916 394
2025
Q1
$916 Buy
51
+11
+28% +$187 ﹤0.01% 293
2024
Q4
$559 Buy
40
+3
+8% +$45 ﹤0.01% 319
2024
Q3
$543 Buy
37
+2
+6% +$32 ﹤0.01% 319
2024
Q2
$651 Sell
35
-92
-72% -$1.79K ﹤0.01% 285
2024
Q1
$2.86K Hold
127
﹤0.01% 255
2023
Q4
$2.96K Buy
127
+42
+49% +$986 ﹤0.01% 256
2023
Q3
$2.39K Hold
85
﹤0.01% 264
2023
Q2
$1.98K Buy
+85
New +$2.17K ﹤0.01% 265
2021
Q2
Sell
-3,622
Closed -$120K 345
2021
Q1
$120K Buy
3,622
+3,035
+517% +$104K ﹤0.01% 221
2020
Q4
$17K Sell
587
-964
-62% -$27.4K ﹤0.01% 313
2020
Q3
$39K Sell
1,551
-13,621
-90% -$434K ﹤0.01% 310
2020
Q2
$452K Buy
+15,172
New +$466K ﹤0.01% 265

Other funds holding INVX

Barrow, Hanley, Mewhinney & Strauss's INVX Position: Q2 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Innovex International (INVX) in Q2 2025, closing a stake of 51 shares — an estimated $916 sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in INVX in Q2 2020 and held it in 12 quarters. The position peaked at $452K in Q2 2020. 168 funds tracked by Wall St. Rank hold INVX as of Q2 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Innovex International position as of Q2 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 51 Innovex International shares in Q2 2025, an estimated $916.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Innovex International in Q2 2020 and held it in 12 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Innovex International position peaked at $452K in Q2 2020.
  • 168 funds tracked by Wall St. Rank held Innovex International as of Q2 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.